title: Production of a suppressor of lymphocyte proliferation by two human oral carcinoma cell lines.
abstract: This study examined the production of an immunosuppressive factor by the KB and H191 human oral squamous carcinoma cell lines. Conditioned media (CM) from both cell lines markedly inhibited mitogen- and alloantigen-induced proliferation of normal human and rat peripheral blood lymphocytes. By contrast, the proliferation of an exponentially-growing fibroblast cell line remained unchanged by CM. The immunosuppressive factor appeared to act after lymphocyte commitment as indicated by continued blast cell formation, the failure of CM to suppress resting lymphocytes and the fact that CM caused maximum inhibition of lymphocyte proliferation 72 h after the addition of PHA. The addition of exogenous IL-2 did not counteract lymphocyte suppression. Inclusion of indomethacin and isoniazid during cell culture did not significantly alter the degree of suppressive activity. Mycoplasma contamination was absent and CM did not act directly with the thymidine or mitogen. The factor was heat stable at 50 degrees C, acid labile and had a molecular weight in excess of 300 kDa. The results demonstrate that human oral squamous carcinoma cell lines produce an immunosuppressive factor that may have a role in tumour evasion of the host immune response.
authors.affiliation: University Department of Oral Medicine, Surgery and Pathology, Bristol Dental School and Hospital, UK.
authors.forename: S Q
authors.initials: SQ
authors.lastname: Rice
authors.forename: I J
authors.initials: IJ
authors.lastname: Crane
authors.forename: C
authors.initials: C
authors.lastname: Scully
authors.forename: S S
authors.initials: SS
authors.lastname: Prime
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000276:immunology*; D002460:Cell Line; D002850:Chromatography, Gel; D003470:Culture Media / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007108:Immune Tolerance / Q000502:physiology*; D007213:Indomethacin / Q000494:pharmacology; D007376:Interleukin-2 / Q000494:pharmacology; D007538:Isoniazid / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects / Q000502:physiology*; D007959:Lymphocyte Culture Test, Mixed; D009062:Mouth Neoplasms / Q000276:immunology*; D013997:Time Factors; D014407:Tumor Cells, Cultured
chemical_list: D003470:Culture Media; D007376:Interleukin-2; D007538:Isoniazid; D007213:Indomethacin